Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2
Nat Chem Biol. 2021 Nov 9
Nat Chem Biol. 2021 Nov 9
Nat Commun. 2021 Nov 9;12(1):6457
Front Public Health. 2021 Oct 20;9:726484
Eur J Med Chem. 2021 Oct 15;222:113584
Vaccine. 2021 Sep 24;39(40):5769-5779
Anal Chem. 2021 Sep 21;93(37):12808-12816
RSC Med Chem. 2021 Aug 20;12(10):1722-1730
PLoS Biol. 2021 Aug 19;19(8):e3001387.
Anal Chem. 2021 Aug 10;93(31):10756-10761.
NPJ Precis Oncol. 2021 Jul 14;5(1):64.
J Infect Dis. 2021 Jul 15;224(Supplement_1):S1-S21.
Curr Opin Virol 2021 Aug;49:81-85 (ePub May 12)
Lancet Respir Med 2021 May;9(5):498-510.
COVID-19: Sci Adv 2021 Feb 5;7(6)):eabe7386.
Viruses. 2020 Dec 26;13(1):29.
Isothermal Amplification and Ambient Visualization in a Single Tube for the Detection of SARS-CoV-2 Using Loop-Mediated Amplification and CRISPR Technology
Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor
Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases
The Interaction of Natural and Vaccine-Induced Immunity with Social Distancing Predicts the Evolution of the COVID-19 Pandemic
Neonatal and Children's Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Molecular Diagnosis of COVID-19: Challenges and Research Needs
Nonessential Research in the New Normal: The Impact of COVID-19
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
COVID-19 and emerging viral infections: The case for interferon lambda
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus